Net Cash Provided by (Used in) Operating Activities |
2.25B |
USD |
+19.2% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
2.6B |
USD |
-10.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
798M |
USD |
+15.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
4B |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
834M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
18.7B |
USD |
+45.3% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
18M |
USD |
+38.5% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
2.94B |
USD |
+9.45% |
Q4 2023 |
FY 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
3.03B |
USD |
+20.9% |
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
27M |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
1.25M |
shares |
+66.7% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
1.25M |
shares |
+66.7% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
242M |
USD |
-0.41% |
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
9.79B |
USD |
+0.68% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Outstanding |
1.25M |
shares |
+66.7% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
119M |
USD |
+7.21% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
2.92B |
USD |
+9.31% |
Q4 2023 |
FY 2023 |
Interest Expense |
4.14B |
USD |
+105% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |